Progesterone (P 4 ) is essential for the establishment and maintenance of pregnancy in mammals and, along with other steroid hormones, is an important variable when considering how to clinically manage endocrine and reproductive diseases. The most extensively studied actions of P 4 on the uterus during the peri-implantation period have focused primarily on changes in gene expression. Progesterone promotes diverse tissue/cellular events such as secretion (e.g., uterine histotroph/milk), cell adhesion, modulation of the maternal immune system, synthesis of trophic factors, and increased angiogenesis for hemotrophic support following implantation [1, 2] . In hemochorial implanting species, P 4 also regulates expression of developmental genes (i.e., Hoxa10, Ihh, Bmp family, and Wnt family) that direct tissue morphogenic events such as stromal decidualization.
Many of the reproductive responses to P 4 have been attributed to activation of classical nuclear P 4 receptors (PGRs), which function primarily as ligand-dependent transcription factors that regulate gene expression [1] . Investigations involving pharmacological inhibitors such as RU486/mifepristone, as well as experiments using mutant mice deficient in PGR expression, have without question established fundamental roles for PGRs in the uterus and other reproductive tissues [3] . However, P 4 signaling in the mammalian uterus during early gestation is complicated by a unique paradox whereby classical PGRs become down-regulated in the epithelium at a time when the embryo first signals its presence in the uterine cavity [4] . So how then does P 4 prepare the epithelium for the implanting embryo in the absence of PGRs? As highlighted in a recent editorial in Biology of Reproduction [4] , the actions of P 4 on the gravid uterine epithelium are thought to occur by an indirect mechanism-the progestamedin hypothesis. This hypothesis is supported by gene expression findings in which P 4 signals the release of numerous growth factors (e.g., fibroblast growth factors and hepatocyte growth factor) from the stromal compartment that, in turn, apparently coordinate epithelial events at the time of embryo implantation.
The PGR-centric progestamedin hypothesis, however, minimizes the likelihood that P 4 signals in the endometrium through mechanisms that do not involve the classical PGR pathway. An alternative or, perhaps more aptly, an additive to the progestamedin hypothesis is that P 4 acts directly on the epithelium during embryo implantation through a PGR-independent mechanism(s). Investigations of Pgr-null mice provide persuasive evidence that not all of the actions of P 4 are accounted for by activation of PGRs [5] . Nonclassical P 4 responses have been examined in the nervous system, sperm, oocyte, and ovary. For example, in the ovary, P 4 signals through a nonclassical pathway to regulate mitosis and apoptosis of granulosa/luteal cells [6] and was recently proposed to regulate early postnatal follicle assembly [7] . Limited examples of nonclassical P 4 responses in the uterus have been described. For instance, the effect of P 4 on uterine sensitivity to oxytocin (OT) involves nonclassical action of P 4 through its direct interaction with the OT receptor [8] . In the ewe, P 4 decreases the release of the luteolytic factor prostaglandin F2a from the endometrium, as well as phosphoinositide hydrolysis [9] , and this response is hypothesized to stem from the direct inhibitory actions of P 4 whereby interactions between OT and its cognate receptor are reduced [9, 10] . While it is overwhelmingly accepted that classical PGRs mediate genomic responses to P 4 in the uterus, Indian hedgehog (Ihh), a gene essential for uterine receptivity and fertility in mice, is transiently up-regulated in the endometrium of PGR-deficient female mice in response to P 4 treatment in vivo, indicating that even P 4 -dependent genomic responses in the uterus are not exclusively coordinated by classical PGRs [11] .
At present, two families of nonclassical progestin receptors have been described in the uterus [12, 13] . With many studies providing compelling evidence supporting a role for nonclassical P 4 signaling, it is time to seriously consider alternative/ additive mechanisms through which P 4 signals outside the transcriptional box in reproductive physiology and disease, and to do so knowing that P 4 likely activates different signaling mechanisms in parallel and/or in series. James K. Pru, Vincent Center for Reproductive Biology, Massachusetts General Hospital
